175 related articles for article (PubMed ID: 29250809)
1. Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
Bergström SH; Järemo H; Nilsson M; Adamo HH; Bergh A
Prostate; 2018 Mar; 78(4):257-265. PubMed ID: 29250809
[TBL] [Abstract][Full Text] [Related]
2. Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
Sjöblom L; Saramäki O; Annala M; Leinonen K; Nättinen J; Tolonen T; Wahlfors T; Nykter M; Bova GS; Schleutker J; Tammela TL; Lilja H; Visakorpi T
PLoS One; 2016; 11(3):e0150241. PubMed ID: 26939004
[TBL] [Abstract][Full Text] [Related]
3. The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target.
Whitaker HC; Warren AY; Eeles R; Kote-Jarai Z; Neal DE
Prostate; 2010 Feb; 70(3):333-40. PubMed ID: 19790236
[TBL] [Abstract][Full Text] [Related]
4. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
Whitaker HC; Kote-Jarai Z; Ross-Adams H; Warren AY; Burge J; George A; Bancroft E; Jhavar S; Leongamornlert D; Tymrakiewicz M; Saunders E; Page E; Mitra A; Mitchell G; Lindeman GJ; Evans DG; Blanco I; Mercer C; Rubinstein WS; Clowes V; Douglas F; Hodgson S; Walker L; Donaldson A; Izatt L; Dorkins H; Male A; Tucker K; Stapleton A; Lam J; Kirk J; Lilja H; Easton D; ; ; ; Cooper C; Eeles R; Neal DE
PLoS One; 2010 Oct; 5(10):e13363. PubMed ID: 20967219
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.
Adamo H; Hammarsten P; Hägglöf C; Dahl Scherdin T; Egevad L; Stattin P; Halin Bergström S; Bergh A
Prostate; 2019 Apr; 79(5):435-445. PubMed ID: 30536410
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
Dahlman A; Rexhepaj E; Brennan DJ; Gallagher WM; Gaber A; Lindgren A; Jirström K; Bjartell A
Mod Pathol; 2011 May; 24(5):708-19. PubMed ID: 21240253
[TBL] [Abstract][Full Text] [Related]
7. Expression study of three secretory proteins (prostatic secretory protein of 94 amino acids, probasin, and seminal vesicle secretion II) in dysplastic and neoplastic rat prostates.
Kwong J; Lui K; Chan PS; Ho SM; Wong YC; Xuan JW; Chan FL
Prostate; 2003 Jul; 56(2):81-97. PubMed ID: 12746832
[TBL] [Abstract][Full Text] [Related]
8. Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
Dahlman A; Edsjö A; Halldén C; Persson JL; Fine SW; Lilja H; Gerald W; Bjartell A
Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):369-75. PubMed ID: 20680031
[TBL] [Abstract][Full Text] [Related]
9. Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers.
Thielen JL; Volzing KG; Collier LS; Green LE; Largaespada DA; Marker PC
Differentiation; 2007 Jan; 75(1):49-61. PubMed ID: 17244021
[TBL] [Abstract][Full Text] [Related]
10. The expression of β-microseminoprotein but not CRISP3 is reduced in ovarian cancer and correlates to survival.
Henriksen R; Lundwall Å; Udby L; Fernlund P
Anticancer Res; 2012 Sep; 32(9):3993-9. PubMed ID: 22993349
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ.
Adamo HH; Halin Bergström S; Bergh A
PLoS One; 2015; 10(6):e0130076. PubMed ID: 26076453
[TBL] [Abstract][Full Text] [Related]
12. Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness.
Adamo HH; Strömvall K; Nilsson M; Halin Bergström S; Bergh A
PLoS One; 2015; 10(11):e0141601. PubMed ID: 26536349
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.
FitzGerald LM; Zhang X; Kolb S; Kwon EM; Liew YC; Hurtado-Coll A; Knudsen BS; Ostrander EA; Stanford JL
Hum Mutat; 2013 Jan; 34(1):149-56. PubMed ID: 22887727
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
15. PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer.
Imasato Y; Xuan JW; Sakai H; Izawa JI; Saito Y; Chin JL; Moussa M
J Urol; 2000 Nov; 164(5):1819-24. PubMed ID: 11025776
[TBL] [Abstract][Full Text] [Related]
16. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
[TBL] [Abstract][Full Text] [Related]
17. Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.
Strömvall K; Thysell E; Halin Bergström S; Bergh A
PLoS One; 2017; 12(5):e0176679. PubMed ID: 28472073
[TBL] [Abstract][Full Text] [Related]
18. Rapidly evolving marmoset MSMB genes are differently expressed in the male genital tract.
Lundwall A; Larne O; Nayudu PL; Ceder Y; Valtonen-André C
Reprod Biol Endocrinol; 2009 Sep; 7():96. PubMed ID: 19737427
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer.
Yeager M; Deng Z; Boland J; Matthews C; Bacior J; Lonsberry V; Hutchinson A; Burdett LA; Qi L; Jacobs KB; Gonzalez-Bosquet J; Berndt SI; Hayes RB; Hoover RN; Thomas G; Hunter DJ; Dean M; Chanock SJ
Hum Genet; 2009 Dec; 126(6):743-50. PubMed ID: 19644707
[TBL] [Abstract][Full Text] [Related]
20. Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer.
Heni M; Hennenlotter J; Scharpf M; Lutz SZ; Schwentner C; Todenhöfer T; Schilling D; Kühs U; Gerber V; Machicao F; Staiger H; Häring HU; Stenzl A
PLoS One; 2012; 7(12):e50953. PubMed ID: 23251408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
